Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

400.67
-8.3500-2.04%
Pre-market: 400.670.00000.00%08:02 EST
Volume:243.08K
Turnover:97.61M
Market Cap:16.38B
PE:23.41
High:414.07
Open:408.38
Low:398.67
Close:409.02
52wk High:435.92
52wk Low:293.43
Shares:40.88M
Float Shares:40.33M
Volume Ratio:0.54
T/O Rate:0.60%
Dividend:4.20
Dividend Rate:1.05%
EPS(TTM):17.12
EPS(LYR):17.12
ROE:34.87%
ROA:10.38%
PB:9.12
PE(LYR):23.41

Loading ...

Macquarie Keeps Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
Oct 21, 2025

Carlisle Companies Inc. : Oppenheimer Cuts Target Price to $415 From $440

THOMSON REUTERS
·
Oct 20, 2025

Carlisle Companies Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 16, 2025

Jarden Remains a Buy on CSL (CMXHF)

TIPRANKS
·
Oct 15, 2025

CSL (CMXHF) Receives a Hold from Bell Potter

TIPRANKS
·
Oct 15, 2025

UBS Keeps Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
Oct 15, 2025

Goldman Sachs Reaffirms Their Buy Rating on Carlisle Companies (CSL)

TIPRANKS
·
Oct 13, 2025

Carlisle Cos Is Maintained at Outperform by Baird

Dow Jones
·
Oct 13, 2025

Carlisle price target lowered to $385 from $440 at Baird

TIPRANKS
·
Oct 13, 2025

CSL Limited Updates Broker for Share Buyback Program

TIPRANKS
·
Oct 13, 2025

How Investors May Respond To CSL (ASX:CSL) Securing NICE Approval and Appointing New CFO

Simply Wall St.
·
Oct 11, 2025

With the portfolio up 35.36% (net) in 6 months, we have been searching for new stocks to drive the next wave of performance. Here are 2 we are adding

LiveWire
·
Oct 10, 2025

CSL (ASX:CSL): Evaluating Valuation After Canadian Access Win for HEMGENIX Gene Therapy

Simply Wall St.
·
Oct 10, 2025

Schroder British Opportunities Trust Invests in CSL Group to Boost IoT Connectivity Expansion

TIPRANKS
·
Oct 07, 2025

CSL Limited Announces Cessation of Securities

TIPRANKS
·
Oct 07, 2025

Shares of CSL Fall After Canada Unit Signs LOI With Pharmaceutical Alliance

MT Newswires Live
·
Oct 07, 2025

Canaccord Genuity Remains a Hold on CSL (CMXHF)

TIPRANKS
·
Oct 06, 2025

CSL (CMXHF) Receives a Buy from UBS

TIPRANKS
·
Oct 06, 2025

CSL Limited Updates on Market Buy-Back Program

TIPRANKS
·
Oct 03, 2025

CSL to Benefit From Immunoglobin Sales Growth, Says Jefferies

MT Newswires Live
·
Oct 02, 2025